These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 34746132)
1. ID2 Inhibits Bladder Cancer Progression and Metastasis Mao W; Wang K; Sun S; Wu J; Chen M; Geng J; Luo M Front Cell Dev Biol; 2021; 9():738364. PubMed ID: 34746132 [No Abstract] [Full Text] [Related]
2. ID2 promotes tumor progression and metastasis in thyroid cancer. Deng Z; Xu M; Ding Z; Kong J; Liu J; Zhang Z; Cao P Endocrine; 2024 Jun; 84(3):1051-1063. PubMed ID: 38195969 [TBL] [Abstract][Full Text] [Related]
3. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer. Liu F; Chen S; Yu Y; Huang C; Chen H; Wang L; Zhang W; Wu J; Ye Y Gene; 2022 Apr; 819():146240. PubMed ID: 35114275 [TBL] [Abstract][Full Text] [Related]
4. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer. Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606 [TBL] [Abstract][Full Text] [Related]
5. HYOU1 promotes cell proliferation, migration, and invasion via the PI3K/AKT/FOXO1 feedback loop in bladder cancer. Wang W; Jiang X; Xia F; Chen X; Li G; Liu L; Xu Q; Zhu M; Chen C Mol Biol Rep; 2023 Jan; 50(1):453-464. PubMed ID: 36348197 [TBL] [Abstract][Full Text] [Related]
6. BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway. Xiao S; Chen J; Wei Y; Song W Eur J Med Res; 2024 May; 29(1):302. PubMed ID: 38811952 [TBL] [Abstract][Full Text] [Related]
7. GREM1 is a potential biomarker for the progression and prognosis of bladder cancer. Jiang PC; Xu LZ; Ning JZ; Cheng F World J Surg Oncol; 2023 Aug; 21(1):255. PubMed ID: 37605239 [TBL] [Abstract][Full Text] [Related]
8. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1. Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637 [TBL] [Abstract][Full Text] [Related]
9. UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway. Qiao L; Dong C; Ma B J Recept Signal Transduct Res; 2022 Apr; 42(2):151-159. PubMed ID: 33435787 [TBL] [Abstract][Full Text] [Related]
10. HEATR3 involved in the cell proliferation, metastasis and cell cycle development of bladder cancer acts as a tumor suppressor. Dou X; Ma X; Meng W; Zhang W; Yang S; Niu F; Xiong Y; Jin T Mol Genet Genomics; 2023 Nov; 298(6):1353-1364. PubMed ID: 37518364 [TBL] [Abstract][Full Text] [Related]
11. TSPAN7 Exerts Anti-Tumor Effects in Bladder Cancer Through the PTEN/PI3K/AKT Pathway. Yu X; Li S; Pang M; Du Y; Xu T; Bai T; Yang K; Hu J; Zhu S; Wang L; Liu X Front Oncol; 2020; 10():613869. PubMed ID: 33489923 [TBL] [Abstract][Full Text] [Related]
12. RAC3 Inhibition Induces Autophagy to Impair Metastasis in Bladder Cancer Cells Wang L; Shi J; Liu S; Huang Y; Ding H; Zhao B; Liu Y; Wang W; Yang J; Chen Z Front Oncol; 2022; 12():915240. PubMed ID: 35847878 [TBL] [Abstract][Full Text] [Related]
13. CSF2 Impairs Nrf2 Signaling through the Akt/Mtor Pathway in the Development of Bladder Cancer. Yu X; Li S; Ke S; Ye C; Wang Q; Wang H; Wang L J Cancer; 2024; 15(11):3242-3253. PubMed ID: 38817867 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway. Zhang C; Chang X; Chen D; Yang F; Li Z; Li D; Yu N; Yan L; Liu H; Xu Z Cancer Manag Res; 2019; 11():7909-7923. PubMed ID: 31692549 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of GAS6 Promotes Cell Proliferation and Invasion in Bladder Cancer by Activation of the PI3K/AKT Pathway. Mao S; Wu Y; Wang R; Guo Y; Bi D; Ma W; Zhang W; Zhang J; Yan Y; Yao X Onco Targets Ther; 2020; 13():4813-4824. PubMed ID: 32547108 [TBL] [Abstract][Full Text] [Related]
16. CircHGS enhances the progression of bladder cancer by regulating the miR-513a-5p/VEGFC axis and activating the AKT/mTOR signaling pathway. Zhu Y; Zuo L; Xiong H; Li S; Chen R; Liu H Cell Cycle; 2023 Apr; 22(8):919-938. PubMed ID: 36617735 [TBL] [Abstract][Full Text] [Related]
17. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway. Qu J; Li J; Zhang Y; He R; Liu X; Gong K; Duan L; Luo W; Hu Z; Wang G; Xia C; Luo D Cell Biosci; 2021 Aug; 11(1):163. PubMed ID: 34419144 [TBL] [Abstract][Full Text] [Related]
18. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer Liao H; Zhang L; Lu S; Li W; Dong W Front Genet; 2022; 13():848926. PubMed ID: 35812733 [No Abstract] [Full Text] [Related]
19. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway. Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468 [TBL] [Abstract][Full Text] [Related]
20. Root extract of Hemsleya amabilis Diels suppresses renal cell carcinoma cell growth through inducing apoptosis and G Li K; You G; Jiang K; Wang R; Li W; Meng Y; Fang Y; Chen W; Zhu G; Song J; Wang W; Su H; Hu B; Sun F; Jia Z; Li C; Zhu J J Ethnopharmacol; 2024 Jan; 318(Pt B):117014. PubMed ID: 37557938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]